Latest News
Read more
Australia’s White-Label Identity Crisis: A Story of Quality, Branding and Margins
As the medical cannabis industry in Australia continues to boom with more patients than ever and the most modern products...
Read more
The New Era of Cannabis in Switzerland, Open Access and Education Lead B SOMAÍ and Dascoli Pharma Partnership
Switzerland has long been a country that wants to create a safe and sustainable future for its population — and...
Read more
SOMAÍ and Lusófona University Publish Peer-Reviewed Study Showcasing Best Practices in Full-Spectrum Cannabis Oil Production
Lisbon, Portugal — [1 July 2025] — SOMAÍ, a leading EU-GMP-certified vertically integrated Multi-Country Operator (MCO) specializing in cannabinoid-based medicines,...
Read more
Michael Sassano about global – Benzinga Cannabis Capital Conference
Throwback to Benzinga’s Cannabis Capital Conference in Chicago — where our Founder & Interim CEO, Michael Sassano, sat down for...
Read more
SOMAÍ Launches New HCP Portals and AI Assistant as Part of Global Website Enhancements
SOMAÍ has announced the launch of dedicated HCP portals in Australia, Germany, and the United Kingdom, as well as the...
Read more
Precision Over Potency: Personalised Cannabis Medicine is Coming of Age
One of the key differences between medical cannabis and other more traditional treatments is the highly personalised nature of how...
Read more
Thailand: The Cannabis Capital of Asia and Beyond
Thailand is already the largest global medical cannabis market, with $1.2 billion in local sales. But that’s not all — Thailand...
Read more
Herer Legacy Goes Global: Dan Herer and Somai Pharmaceuticals Bring the Jack Herer Standard to the World
Dan Herer, son of the legendary Jack Herer, partners with Somai Pharmaceuticals to take the Herer standard worldwide. Blending grassroots...